4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-22-037110
Chief Financial Officer bought 66,452 shares at an average $2.42 ($160,798)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2022-06-13 | Purchase | +7,596 | $2.08 | $15,813 | 96,596 | D |
| Byam Rebecca Chief Financial Officer | 2022-06-14 | Purchase | +58,856 | $2.46 | $144,986 | 155,452 | D |
| Open-market purchases · 66,452 sh · avg $2.42 · $160,798 | |||||||
Loading xslF345X03/doc4.xml…